BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 37130177)

  • 1. Diagnostic of Cytokeratin-19 Gene Expression in Iranian Breast Cancer Patients.
    Heidary Pour A; Mansouri N; Kolahi AA; Hassanian-Moghaddam H; Rezaei Tavirani M; Mazloumi Z; Motallebi M; Movafagh A; Iriti M
    Cell Mol Biol (Noisy-le-grand); 2022 Dec; 68(12):74-78. PubMed ID: 37130177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of gene expression in sentinel lymph node of primary breast cancer patients.
    Soleimani S; Alizadeh Shargh S; Keramatinia A; Mehrvar N; Mansouri N; Doosti A; Mortazavi-Tabatabaei SA; Hashemi M; Movafagh A
    Cell Mol Biol (Noisy-le-grand); 2018 Apr; 64(5):118-121. PubMed ID: 29729704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Total Tumor Load of mRNA Cytokeratin 19 in the Sentinel Lymph Node as a Predictive Value of Axillary Lymphadenectomy in Patients with Neoadjuvant Breast Cancer.
    Peña KB; Kepa A; Cochs A; Riu F; Parada D; Gumà J
    Genes (Basel); 2021 Jan; 12(1):. PubMed ID: 33435629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intra-operative rapid diagnostic method based on CK19 mRNA expression for the detection of lymph node metastases in breast cancer.
    Visser M; Jiwa M; Horstman A; Brink AA; Pol RP; van Diest P; Snijders PJ; Meijer CJ
    Int J Cancer; 2008 Jun; 122(11):2562-7. PubMed ID: 18324628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [mRNA expression of CK19 and CEA in peripheral blood of patients with breast cancer detected by real-time quantitative PCR].
    Zheng HY; Chen Q; Ye YB; Huang WW
    Zhonghua Yi Xue Za Zhi; 2008 Aug; 88(32):2267-70. PubMed ID: 19087676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. One-step nucleic acid amplification (OSNA) for intraoperative evaluation of sentinel lymph node status in breast cancer: a comparative study between CK19 protein expression and CK19 mRNA level in primary tumors and lymph node metastasis.
    Pegolo E; Puppin C; Gerometta A; Damante G; Puglisi F; Di Loreto C
    Virchows Arch; 2013 Jul; 463(1):7-15. PubMed ID: 23779101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the histological size of the sentinel lymph node metastases using RT-PCR assay: a rapid tool to estimate the risk of non-sentinel lymph node invasion in patients with breast cancer.
    Veys I; Majjaj S; Salgado R; Noterman D; Schobbens JC; Manouach F; Bourgeois P; Nogaret JM; Larsimont D; Durbecq V
    Breast Cancer Res Treat; 2010 Dec; 124(3):599-605. PubMed ID: 19779817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive Value of Clinicopathological Characteristics for Sentinel Lymph Node Metastasis in Early Breast Cancer.
    Ding J; Jiang L; Wu W
    Med Sci Monit; 2017 Aug; 23():4102-4108. PubMed ID: 28839123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical application of the one-step nucleic acid amplification method to detect sentinel lymph node metastasis in breast cancer.
    Sagara Y; Ohi Y; Matsukata A; Yotsumoto D; Baba S; Tamada S; Sagara Y; Matsuyama Y; Ando M; Rai Y; Sagara Y
    Breast Cancer; 2013 Apr; 20(2):181-6. PubMed ID: 22203582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene promoter hypermethylation is found in sentinel lymph nodes of breast cancer patients, in samples identified as positive by one-step nucleic acid amplification of cytokeratin 19 mRNA.
    Martín-Sánchez E; Pernaut-Leza E; Mendaza S; Cordoba A; Vicente-Garcia F; Monreal-Santesteban I; Vizcaino JP; De Cerio MJ; Perez-Janices N; Blanco-Luquin I; Escors D; Ulazia-Garmendia A; Guerrero-Setas D
    Virchows Arch; 2016 Jul; 469(1):51-9. PubMed ID: 27097811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A cut-off of 2150 cytokeratin 19 mRNA copy number in sentinel lymph node may be a powerful predictor of non-sentinel lymph node status in breast cancer patients.
    Terrenato I; D'Alicandro V; Casini B; Perracchio L; Rollo F; De Salvo L; Di Filippo S; Di Filippo F; Pescarmona E; Maugeri-Saccà M; Mottolese M; Buglioni S
    PLoS One; 2017; 12(2):e0171517. PubMed ID: 28187209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CK19 expression in breast tumours and lymph node metastasis after neoadjuvant therapy.
    Vieites B; López-García MÁ; Castilla C; Hernández MJ; Biscuola M; Alfaro L; Atienza MR; Castilla MÁ; Palacios J
    Histopathology; 2016 Aug; 69(2):239-49. PubMed ID: 26708058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reliability of whole sentinel lymph node analysis by one-step nucleic acid amplification for intraoperative diagnosis of breast cancer metastases.
    Castellano I; Macrì L; Deambrogio C; Balmativola D; Bussone R; Ala A; Coluccia C; Sapino A
    Ann Surg; 2012 Feb; 255(2):334-42. PubMed ID: 21975319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction score model for non-sentinel and four or more nodal metastases using a combined method of one-step nucleic acid amplification and histology in sentinel node-positive breast cancer patients.
    Jimbo K; Kinoshita T; Ogura T; Watase C; Murata T; Shiino S; Takayama S; Yoshida M
    Eur J Surg Oncol; 2020 Apr; 46(4 Pt A):516-521. PubMed ID: 31711717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sentinel node biopsy and cytokeratin staining for the accurate staging of 478 breast cancer patients.
    Pendas S; Dauway E; Cox CE; Giuliano R; Ku NN; Schreiber RH; Reintgen DS
    Am Surg; 1999 Jun; 65(6):500-5; discussion 505-6. PubMed ID: 10366202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The association of cytokeratin-only-positive sentinel lymph nodes and subsequent metastases in breast cancer.
    Mullenix PS; Brown TA; Meyers MO; Giles LR; Sigurdson ER; Boraas MC; Hoffman JP; Eisenberg BL; Torosian MH
    Am J Surg; 2005 May; 189(5):606-9; discussion 609. PubMed ID: 15862505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breast cancer metastasis burden in sentinel nodes analysed using one-step nucleic acid amplification predicts axillary nodal status.
    Milner TD; de Lusignan S; Jones S; Jackson PA; Layer GT; Kissin MW; Irvine TE
    Breast; 2015 Oct; 24(5):568-75. PubMed ID: 26032111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sentinel lymph node micrometastasis as a predictor of axillary tumor burden.
    Dabbs DJ; Fung M; Landsittel D; McManus K; Johnson R
    Breast J; 2004; 10(2):101-5. PubMed ID: 15009035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of additional lymph node involvement in breast cancer patients with positive sentinel lymph nodes.
    Pohlodek K; Bozikova S; Meciarova I; Mucha V; Bartova M; Ondrias F
    Neoplasma; 2016; 63(3):427-34. PubMed ID: 26925789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the Metasin assay for intraoperative assessment of sentinel lymph node metastases in breast cancer.
    Smith GJ; Hodges E; Markham H; Zhang S; Cutress RI
    J Clin Pathol; 2017 Feb; 70(2):134-139. PubMed ID: 27406050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.